|
|||||
|
|
A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults |
|
| Authors: | Fumihiko Sakai MD PhD Takao Takeshima MD PhD Yoshihisa Tatsuoka MD PhD Koichi Hirata MD PhD Robert Lenz MD PhD Yi Wang PhD Sunfa Cheng MD Toshiyasu Hirama MD PhD Daniel D. Mikol MD PhD |
| Affiliation: | 1. Saitama International Headache Center, Saitama, Japan;2. Headache Center, Department of Neurology, Tominaga Hospital, Osaka, Japan;3. Department of Neurology, Tatsuoka Neurology Clinic, Kyoto, Japan;4. Department of Neurology, Dokkyo Medical University, Tochigi, Japan;5. Global Development, Amgen Inc., Thousand Oaks, CA, USA;6. Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA;7. Research & Development, Amgen Astellas BioPharma K.K., Tokyo, Japan |
| Abstract: | |
| Keywords: | erenumab phase 2 trial headache episodic migraine migraine prevention |